Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fisetin and Losartan with BMAC for Knee Osteoarthritis
NCT04815902Phase 2Active, not recruiting
- Sponsor
- Steadman Philippon Research Institute
- Start
- May 2021
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fisetin, losartan in osteoarthritis (OA), sponsored by Steadman Philippon Research Institute. Started May 2021; status: active, not recruiting.
02
Drugs
fisetinlosartan
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04815902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04815902.